Organizations need to take a proactive approach to identify, prioritize and mitigate threats in real time. This means gaining visibility and control into all physical and virtual assets.

The post A Preemptive Prescription to Cyber Exposure Management appeared first on MedCity News.

Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.

The post How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic appeared first on MedCity News.

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market.

The post Why Is Medtronic Spinning Off Its Diabetes Business? appeared first on MedCity News.

Allowing hospitals to repair the equipment they depend upon daily is not a step backward, but a reaffirmation of trust in the skilled and deeply committed professionals who already maintain the integrity of our healthcare systems.

The post Rebuttal: Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.

In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.

The post MedCity Pivot Podcast: Precision Medicine with the CEO of Helix appeared first on MedCity News.

Startup finalists competed in four tracks: biopharma; devices and diagnostics; health tech aimed at consumers and self-insured employers; and health tech aimed at payers and providers. Investor judges in each track selected the winners.

The post Who Won MedCity INVEST Pitch Perfect? appeared first on MedCity News.

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting a new life by joining Regeneron Genetics Center, a Regeneron subsidiary that analyzes genetic data for drug R&D.

The post 23andMe Bankruptcy Auction Win Adds Big Piece to Regeneron’s Gene-Based Drug R&D Efforts appeared first on MedCity News.

ZEM Life is developing a smartwatch that can deliver Narcan to combat a fentanyl overdose.

The post How One Company Aims to Save Lives with Its Smartwatch appeared first on MedCity News.

Israeli cancer diagnostics startup SpotitEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year.

The post Meet the Startup Using Dogs to Sniff Out Cancer appeared first on MedCity News.

To prepare for an autonomous surgical future, medtech leaders should explore the practical implications of potential scenarios, and structure investment accordingly. The key is to develop a living roadmap that drives decisions on a day-by-day basis, drawing on macro- and micro-trends.

The post Imagine Reshaping The Surgical Landscape With Autonomous Surgery appeared first on MedCity News.

[Sponsored] PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical development to market access — in a May 22 webinar.

The post Improving the Patient Journey in Drug Development appeared first on MedCity News.

[Sponsored] In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding.

The post Investors Share How Early Stage Healthcare and Life Science Startups Can Make the Most of New Opportunities appeared first on MedCity News.

The trouble is that our technical colleagues know how to build beautiful products, but most have not worked within the four walls of healthcare, very seldom within the operating room. As a result, they do not know what will work or what is sufficient to drive engagement. What’s needed is collaboration.

The post Why Clinician Involvement is Essential to Driving Hospital Innovation appeared first on MedCity News.

Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California.

The post FDA Approves First At-Home Cervical Cancer Test appeared first on MedCity News.

Through a new partnership, Babyscripts members now have access to Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor.

The post Withings, Babyscripts Team Up to Tackle Hypertensive Disorders of Pregnancy appeared first on MedCity News.

[Sponsored] A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they’re advising startups in the wake of cuts to NIH and SBIR grants.

The post Get a Snapshot of the Early Stage Life Science Startup Landscape appeared first on MedCity News.

It’s time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management.

The post Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs appeared first on MedCity News.

[Sponsored] Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick.

The post What Do Early Stage Life Science Companies Need to Grow? appeared first on MedCity News.

MedCity INVEST is a boutique healthcare investor conference scheduled for May 20-21 at the Willis Tower in Chicago. Register today!

The post Time is Running Out to Join the Healthcare Innovation Conversation at INVEST 2025 appeared first on MedCity News.

German medical device company seca released the first portable body composition scanner designed for primary care. The scanner seeks to give primary care providers a more accurate picture of their patient’s health, as well as help them spot certain conditions — such as sarcopenia, obesity and metabolic disorders — earlier.

The post Seca Launches First Portable Body Composition Scan for Primary Care appeared first on MedCity News.

April has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, AdventHealth and DexCare both named new CEOs, and Crozer Health and UNC Health have undergone CEO exits. There were also layoffs at organizations including Aetna, Sanford Health and Caribou Biosciences.

The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

[Sponsored] Sign up today and and join us on May 8th where we’ll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.

The post Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies appeared first on MedCity News.

EMS providers often treat patients without medical history, risking delays, errors, and guesswork. But new national data-sharing frameworks are starting to close that gap, bringing critical records to first responders in real time.

The post Bringing Patient Data to the Frontlines: Why Interoperability Must Include EMS appeared first on MedCity News.

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.

The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.

Contraline released promising new trial data showing that its male contraceptive gel has demonstrated safety and efficacy in the first two trial participants to reach the two-year mark. The company is aiming to earn the product’s FDA approval by the end of 2028, according to CEO Kevin Eisenfrats.

The post Trial Data Shows ‘IUD for Men’ Is Effective for 2 Years appeared first on MedCity News.

Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success.

The post Clinician Adoption: How HealthTech Can Overcome Key Barriers appeared first on MedCity News.

How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?”

The post Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.

[Sponsored] A webinar on May 8th will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.

The post How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow? appeared first on MedCity News.

Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days.

The post Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App appeared first on MedCity News.

These recommendations on how to care for babies who fail newborn screenings offer valuable lessons for public health officials, clinicians, and families.

The post Beyond Newborn Screening: Four Essential Factors in Congenital Disease Care appeared first on MedCity News.